Evidence of Desensitization by Sublingual Immunotherapy in Peanut-Allergic Children
In this double-blind, placebo-controlled study, subjects underwent 6 months of dose escalation to a total of 2000 mcg of peanut protein daily and 6 months of maintenance dosing followed by a double-blind, placebo-controlled food challenge (DBPCFC).
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2011-02, Vol.127 (2), p.AB72-AB72 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In this double-blind, placebo-controlled study, subjects underwent 6 months of dose escalation to a total of 2000 mcg of peanut protein daily and 6 months of maintenance dosing followed by a double-blind, placebo-controlled food challenge (DBPCFC). |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2010.12.296 |